Cargando…
WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal
Autores principales: | Kruger, Donna, Prathapan, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439010/ https://www.ncbi.nlm.nih.gov/pubmed/32839756 http://dx.doi.org/10.1016/j.jtauto.2020.100062 |
Ejemplares similares
-
Azithromycin: The First Broad-spectrum Therapeutic
por: Firth, Anton, et al.
Publicado: (2020) -
Broad-spectrum therapeutics: A new antimicrobial class
por: Firth, Anton, et al.
Publicado: (2020) -
Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011) -
WITHDRAWN: Early combination therapy with
hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19
outpatients
por: Million, Matthieu, et al.
Publicado: (2021) -
dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)